Emory University School of Medicine/Winship Cancer Institute is a clinical research site located in Atlanta, Georgia, United States 30322.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
Emory University School of Medicine/Winship Cancer Institute has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program, Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).
Sponsors: Novartis Pharmaceuticals.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Emory University School of Medicine/Winship Cancer Institute has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Emory University School of Medicine/Winship Cancer Institute has 5 clinical trials on record, with 1 currently active. Their work covers Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program, Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).
Emory University School of Medicine/Winship Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.